Clinical trial

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in…

NCT00246376 · Baylor College of Medicine, Other · Completed

Key facts

NCT number NCT00246376
Title Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Official title Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Acronym HeartPositive
Lead sponsor Baylor College of Medicine, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH Legacy Community Health Center
Status Completed
Study type Interventional
Conditions Cardiovascular Diseases, Heart Diseases, HIV Infections, Hyperlipidemia, Hypertriglyceridemia, Insulin Resistance, Atherosclerosis
Intervention type Behavioral, Drug, Other
Interventions Diet, Exercise, Niacin, Fenofibrate, Placebos
Enrollment 221
Start date Jan 1, 2004
Primary completion Sep 1, 2009
Completion Feb 1, 2012
First posted Oct 31, 2005
Last update posted Mar 21, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies